Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Oligodendroglioma 1 Neoplasms 1 Glioma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Extensive Stage Lung Small Cell Carcinoma 1 Colorectal Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Oxaliplatin 29 Fluorouracil 25 Leucovorin 20 Capecitabine 18 Irinotecan 17 Surveys and Questionnaires 16 Bevacizumab 14 Cisplatin 12 Blood Specimen Collection 11 Drug Therapy 10 Standard of Care 9 Nivolumab 9 Gemcitabine 9 Cetuximab 7 pembrolizumab 6 Specimen Handling 6 S 1 (combination) 6 Endoscopic Mucosal Resection 6 Cyclophosphamide 6 atezolizumab 5 Sunitinib 5 Radiotherapy 5 Folfox protocol 5 Educational Status 5 Docetaxel 5 fludarabine 4 aldesleukin 4 Radiosurgery 4 Pemetrexed 4 Magnetic Resonance Spectroscopy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Gastrointestinal Neoplasms × LB100 × Clear all

NCT06012734 2024-08-30

CoLBAt

The Netherlands Cancer Institute

Phase 1 Recruiting

Gastrointestinal

Gastrointestinal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡